Reaction
Staphylococcal Skin Infection reporting signals
As of the last recalculation, Staphylococcal Skin Infection appears in 1,220 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ATOVAQUONE (PRR 23.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atovaquone | 11 | 23.5 | 23.5 |
| Valganciclovir Hydrochloride Powder, | 15 | 21.2 | 21.3 |
| Baricitinib | 9 | 16.0 | 16.1 |
| Mupirocin | 12 | 15.3 | 15.3 |
| Mupirocin Calcium | 12 | 15.0 | 15.0 |
| Valganciclovir | 15 | 13.7 | 13.7 |
| Valganciclovir Hydrochloride | 15 | 13.7 | 13.7 |
| Amphotericin B | 10 | 13.7 | 13.7 |
| Panitumumab | 12 | 13.2 | 13.2 |
| Ixekizumab | 13 | 6.0 | 6.1 |
| Crisaborole | 3 | 5.3 | 5.3 |
| Natalizumab | 47 | 4.5 | 4.5 |
| Salicylic Acid | 4 | 1.3 | 1.3 |
| Adapalene | 8 | 0.7 | 0.7 |